Study finds 2 competing opioid treatments have similar outcomes; GOP tax bill includes repeal of the ACA's individual mandate; and a study finds a correlation between screen time and depression in teenage girls.
A recent study has found that 2 of the main treatments for opioid addiction, Vivitrol and Suboxone, have similar outcomes. According to The New York Times, researchers found that 52% of those who started on Vivitrol, a monthly shot that blocks the effects of opioids, relapsed during the 24-week study. For those who started on Suboxone, a daily strip that dissolves on the tongue and contains a mild opioid that helps minimize withdrawal symptoms and cravings, there was a 56% relapse rate.
On Tuesday, Senate Republican leaders announced that their tax bill will include a provision repealing the Affordable Care Act (ACA)'s individual mandate, reported The Washington Post. The mandate requires Americans to purchase health insurance or else pay a fine. According to the Congressional Budget Office (CBO), the repeal of the mandate would free up over $300 billion in government funding over the next decade that Republicans can utilize to finance their proposed tax cuts, but it would result in 13 million fewer people having health insurance. CBO also estimated that repealing the mandate would increase insurance premiums by roughly 10% for many Americans.
According to NPR, a recent study has found that increased hours spent on computers, cell phones, and other electronic devices might have contributed to the increase in symptoms of depression and suicidal thoughts in teens, especially girls, over the last several years. Reponses to national surveys showed that between 2010 and 2015, the proportion of teen girls who answered “yes” to 3 or more questions about having symptoms of depression increased from 16% to 22%.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More